Result Based Financing: Screening for Cervical Cancer in Thailand

Size: px
Start display at page:

Download "Result Based Financing: Screening for Cervical Cancer in Thailand"

Transcription

1 Result Based Financing: Screening for Cervical Cancer in Thailand Grit Leetongin, MD. National Health Security Office, Thailand 21 November 2011 Why Cervical Cancer Screening? Cervical cancer is an important public health problem, comprises approximately 12% of all cancers in women; In Thailand, prevalence 20-25/100,000 female population, first top women cancer and third cause of death from cancer in women; Cervical screening is the most effective approach for cervical cancer control. Nordic countries have shown that well-organized cytology screening programmes have reduced mortality from cervical cancer by approximately 60%. Cervical cancer screening in developing countries : report of a WHO consultation

2 Why we can? Ministry of Public Health take leadership and centralized decision making; Health care infrastructures mostly are government and expand around Thailand; Funding from Universal coverage funds managed by National Health Security Office; Technical support and monitoring by National Cancer Institute, Department of Medicine 3 Cervical cancer prevention program goals Intermediate goals Increase coverage of screening (80% of female between 30 and 60 were screened) Increase cervical cancer detection rate, all +ve screening receive proper management and follow up. Ultimate goals Decrease mortality of cervical cancer 4 2

3 Target group and screening Target group: women aged years Screening method: Pap smear for women aged years, VIA for women aged years Screening frequency: every 5 years Organized population screening in addition to opportunistic screening VIA: Visual inspective and acetic acid applications 5 Design for CA cervix screening design until currently capitation Target group Screening frequency 250 /case of CA Cx screening 230 /case of VIA c treatment Women age, 5 year intervals 35,40,45,50,55,60 Every 5 years 250 /case of CA Cx screening 230 /case of VIA c treatment Any women yr. assume everyone never screening same No. of Target 4 M/5 years, (800,000/year) 13 M/5 years, (2.6 M/year) Technical support National Cancer Institute Mgt unit NHSO NHSO Payment to Payment method Information From: NHSO 2010 Directly to CUP and to PCU via NHSO provincial branch Postpaid-every three months Summary report, Pap registry (Individual record) National Cancer Institute Directly to CUP and to PCU via NHSO provincial branch Postpaid-every three months and now prepaid Pap registry (Individual record) 6 3

4 Relationship between NHSO, front line service providers and NCI 2010 Result verification NHSO Individual records on the result of screening NC I Result verification Lump sum Pap = 250 VIA = 70 Send data Send data Staffs Incentives depends on CUP CUP & Network Send data Cytology unit Finding cases Specimen and payment for screening, for Pap [VIA is not paid as its self containing service Smear reader, randomized recheck for negative smear 7 Existing active in-service Cytologists: 338 Supply side service planning between NHSO and NIC for scaling up in 2010, when money is not a problem, supply side capacities are critical success factors Expected number of services [slides] Workloads Total slides screened In office hours 40 slides per day 13,520 Overtime works Total annual services rendered days 2,700,000 Per year, assume half of daytime workload 1,350,000 Annual 4,050,

5 Screening Results Target : women aged 35,40,45,50,55,60 years total No. of screening 405, , , , ,341 2,904,339 Normal 402, , , , ,994 2,877,520 Abnormal 3,169 5,227 6,474 5,602 6,347 26,819 Low Grade 1,814 2,908 3,830 3,259 2,979 14,790 High Grade 1,141 2,013 2,309 2,002 1,699 9,164 Cancer , : coverage of women population aged years % 9 Screening Results Target : women aged years (at May) No. of screening 2,195, ,792 Normal 2,170, ,403 Abnormal 24,957 10,389 Low Grade 15,177 6,841 High Grade 8,565 3,190 Cancer 1, : coverage of women population aged years % 10 5

6 Coverage of CA Cx Screening in women population aged years (%) year NSO : REPRODUCTIVE HEALTH SERVEY 2006,2009 Challenges Needs audit to prevent frauds and false reporting, Individual records useful to recheck, NHSO pays upon receipt of pap reading results from NCI Need to ensure a seamless link between the positive screened cases and cancer admissions/ treatment Limit number of cytologists for Pap reading constrains further massive scaling up, More cost effective VIA are being promoted, 12 6

7 Lessons learned Payment method: postpaid and prepaid effect - screening delivery, - data (no record or over key record) Thank you for your attention 7

SUMAR Program s Universal Coverage: achievements and new goals towards 2020

SUMAR Program s Universal Coverage: achievements and new goals towards 2020 SUMAR Program s Universal Coverage: achievements and new goals towards 2020 4 Introductory Concepts 1. Argentina is a federal country where provincial governments are responsible for the provision of healthcare.

More information

The new European (and Italian) guidelines for cervical screening will recommend PAP from 25 to 34 HPV (+ triage) from 35 to 64

The new European (and Italian) guidelines for cervical screening will recommend PAP from 25 to 34 HPV (+ triage) from 35 to 64 The new European (and Italian) guidelines for cervical screening will recommend PAP from 25 to 34 HPV (+ triage) from 35 to 64 risk of overdiagnosis and over treatment Failures in reproductive functioning:

More information

Cost-effectiveness, Affordability, and Financing of Cervical Cancer Prevention

Cost-effectiveness, Affordability, and Financing of Cervical Cancer Prevention Cost-effectiveness, Affordability, and Financing of Cervical Cancer Prevention Dr. Carol Levin PATH Video transcript is located below each slide. Cost-effectiveness, Affordability, and Financing of Cervical

More information

SCALING UP VIA AND CRYOTHERAPY: Challenges, Opportunities and Essential Program Practices

SCALING UP VIA AND CRYOTHERAPY: Challenges, Opportunities and Essential Program Practices SCALING UP VIA AND CRYOTHERAPY: Challenges, Opportunities and Essential Program Practices PANEL PRESENTATION Ricky Lu, MD, MPH XX FIGO WORLD CONGRESS FIERA di ROMA, ITALY 10 OCTOBER 2012 SESSION OUTLINE

More information

HIV Status Effect on Cervical Cancer Screening in Three Countries: Paper Presentation

HIV Status Effect on Cervical Cancer Screening in Three Countries: Paper Presentation HIV Status Effect on Cervical Cancer Screening in Three Countries: Paper Presentation Jean Anderson, MD Johns Hopkins Medical Institutions Megan Wysong, MPH M&E Team Lead, Jhpiego/USA John E. Varallo,

More information

European Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs

European Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs European Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs Introduction to the Survey The purpose of this project is to collect information regarding

More information

Cervical cancer screening in Norway

Cervical cancer screening in Norway Cervical cancer screening in Norway «The future of cancer screening in Estonia: health benefits and best practices» 17 November 2016, Tartu Stefan Lönnberg Cancer Registry of Norway Screening governance

More information

Clinical Evaluation: Combined Visual Inspection and Pap for Cervical Cancer Prevention

Clinical Evaluation: Combined Visual Inspection and Pap for Cervical Cancer Prevention Clinical Evaluation: Combined Visual Inspection and Pap for Cervical Cancer Prevention Clínica Fara, Matagalpa, Nicaragua Susan Howe, MPH Dra. Oneyda Chavarria D, MD Dr. Kay Edwards, Ph.D, Haverford College

More information

CERVICAL SCREENING WALES CERVICAL SCREENING PROGRAMME, WALES: 2001/02

CERVICAL SCREENING WALES CERVICAL SCREENING PROGRAMME, WALES: 2001/02 CERVICAL SCREENING WALES INFORMATION TEAM STATISTICAL REPORT CERVICAL SCREENING PROGRAMME, WALES: 2001/02 For more information about this report contact: Helen Beer, Information Analyst / Manager, Screening

More information

Course Title: Thin Prep PAP Smears. Number of Clock Hours: 3 Course Title #

Course Title: Thin Prep PAP Smears. Number of Clock Hours: 3 Course Title # Course Title: Thin Prep PAP Smears Number of Clock Hours: 3 Course Title #5240303 Course Introduction There is a new laboratory test that is gaining popularity as a cancer screening tool for cervical cancer.

More information

HPV-Negative Results in Women Developing Cervical Cancer: Implications for Cervical Screening Options

HPV-Negative Results in Women Developing Cervical Cancer: Implications for Cervical Screening Options HPV-Negative Results in Women Developing Cervical Cancer: Implications for Cervical Screening Options R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center (UPMC) (raustin@magee.edu)

More information

HPV vaccine introduction and implementation. Experience from Sri Lanka

HPV vaccine introduction and implementation. Experience from Sri Lanka HPV vaccine introduction and implementation Experience from Sri Lanka Dr. Deepa Gamage Consultant Medical Epidemiologist Epidemiology Unit Ministry of Health Sri Lanka Presentation outline Evidence generation

More information

EUROCHIP-II FINAL SCIENTIFIC REPORT ANNEX 08 REPORT OF ESTONIA

EUROCHIP-II FINAL SCIENTIFIC REPORT ANNEX 08 REPORT OF ESTONIA EUROCHIP-II FINAL SCIENTIFIC REPORT ANNEX 08 REPORT OF EUROCHIP-2 ACTION IN ESTONIA Impact of implementing a nationwide cervical cancer screening programme on population coverage by Pap-tests and on proportion

More information

Healthy Caribbean 2012 Rallying for Action on NCDs

Healthy Caribbean 2012 Rallying for Action on NCDs Healthy Caribbean 2012 Rallying for Action on NCDs Regional Strategy and Plan of Action for Cervical Cancer 27 May, 2012, Kingston, Jamaica Dr Tomo Kanda Advisor on Chronic Diseases & Mental Health PAHO

More information

Department of Health Standard for the Cervical Cancer Screening Program. Approval Date: 08 May 2018 Effective Date: 13 May 2018

Department of Health Standard for the Cervical Cancer Screening Program. Approval Date: 08 May 2018 Effective Date: 13 May 2018 Document Title: Department of Health Standard for the Cervical Cancer Screening Program Document Ref. Number: DOH/CCSC/SD/1.0 Version: 1.0 Approval Date: 08 May 2018 Effective Date: 13 May 2018 Last Reviewed:

More information

Lessons learnt from cancer screening programmes as an example for establishing the Czech National Coordination Centre

Lessons learnt from cancer screening programmes as an example for establishing the Czech National Coordination Centre Czech National Coordination Centre for Prevention of Serious Diseases CZ.03.2.63/0.0/0.0/15_039/0006904 Lessons learnt from cancer screening programmes as an example for establishing the Czech National

More information

Changes to cervical screening. Information for patients

Changes to cervical screening. Information for patients Changes to cervical screening Information for patients On December 1, 2017, cervical cancer screening in Australia changed from two-yearly Pap testing to five-yearly HPV testing. Why has cervical screening

More information

Details of HPV-based Cervical Cancer Screening in Turkey

Details of HPV-based Cervical Cancer Screening in Turkey Details of HPV-based Cervical Cancer Screening in Turkey Murat Gultekin, MD, Assoc. Prof., Gyn Oncol Divison Cervical Cancer in Turkey Incidence: 4-5 /100.000 (Years 2004-2015) Annual New Cases: 1.800

More information

How can the vulnerability of mobile populations (affected by infrastructure programmes) be reduced?

How can the vulnerability of mobile populations (affected by infrastructure programmes) be reduced? The Problem. How can the vulnerability of mobile populations (affected by infrastructure programmes) be reduced? Response. Ensure that all standard contracts financed from multilateral and bilateral resources

More information

Partha Basu M.D. Screening Group/ Early Detection & Prevention Section

Partha Basu M.D. Screening Group/ Early Detection & Prevention Section Current Status of Quality Assured Colposcopy Practice in South Asia Partha Basu M.D. Screening Group/ Early Detection & Prevention Section Disclosures No financial disclosure NO conflict of interest to

More information

Mapping of Pap smear quality and results using routinely collected South African health facility data

Mapping of Pap smear quality and results using routinely collected South African health facility data Mapping of Pap smear quality and results using routinely collected South African health facility data Caroline Makura 14 April 2016 Kathryn Schnippel, Pamela Michelow, Carla Chibwesha, Bridgette Goieman,

More information

Treatment as prevention: Will it work in Thailand?

Treatment as prevention: Will it work in Thailand? Treatment as prevention: Will it work in Thailand? Tanarak Plipat Department of Disease Control, Ministry of Public Health Thailand MoPH US CDC Collaboration Treatment as prevention Thailand: country background

More information

Dennis P. Scanlon, Ph.D. Jeff Beich, Ph.D. Patti Simino Boyce RN, Ph.D. AcademyHealth, June 30, 2009

Dennis P. Scanlon, Ph.D. Jeff Beich, Ph.D. Patti Simino Boyce RN, Ph.D. AcademyHealth, June 30, 2009 Dennis P. Scanlon, Ph.D. Jeff Beich, Ph.D. Patti Simino Boyce RN, Ph.D. AcademyHealth, June 30, 2009 Many policymakers and stakeholder organizations have suggested the need for sustainable community level

More information

Winnable Battles: Cancer in Colorado. Joni Reynolds, RN-CNS, MSN Director of Public Health Programs

Winnable Battles: Cancer in Colorado. Joni Reynolds, RN-CNS, MSN Director of Public Health Programs Winnable Battles: Cancer in Colorado Joni Reynolds, RN-CNS, MSN Director of Public Health Programs Challenging Disparities Freedom Sculpture by Zenos Frudakis CRC 5 Year Cause Specific Survival Rates 49%

More information

NATIONAL CERVICAL CANCER SCREENING PROGRAMME Monitor 2017

NATIONAL CERVICAL CANCER SCREENING PROGRAMME Monitor 2017 a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a NATIONAL CERVICAL CANCER SCREENING PROGRAMME Monitor

More information

BODY RESPONSIBLE FOR IMPLEMENTING THE SCHEME

BODY RESPONSIBLE FOR IMPLEMENTING THE SCHEME TITLE OF THE SCHEME School Fruit and Vegetables Scheme 2015-2016 Page 1 of 7 LEGAL BASIS 1. Council Regulation (EU) No 1370/2013 of 16 December 2013. 2. Regulation (EU) No 1308/2013 of the European Parliament

More information

Cytopathology. Robert M Genta Pathologie Clinique Université de Genève

Cytopathology. Robert M Genta Pathologie Clinique Université de Genève Cytopathology Robert M Genta Pathologie Clinique Université de Genève Learning objectives At the end of this hour you will know: 1. What cytopathology is 2. How specimens are collected, processed, and

More information

Council Regulation (EC) No 1234/2007, as amended by Regulation (EC) No 13/2009 of 18 December 2008.

Council Regulation (EC) No 1234/2007, as amended by Regulation (EC) No 13/2009 of 18 December 2008. Title of Scheme School Fruit and Vegetable Scheme 2011-2012 Legal basis Council Regulation (EC) No 1234/2007, as amended by Regulation (EC) No 13/2009 of 18 December 2008. Commission Regulation (EC) No

More information

Streamlining Protocols-From Strategy to Implementation. Doreen Ramogola-Masire Botswana UPenn Partnership June 2014

Streamlining Protocols-From Strategy to Implementation. Doreen Ramogola-Masire Botswana UPenn Partnership June 2014 Streamlining Protocols-From Strategy to Implementation Doreen Ramogola-Masire Botswana UPenn Partnership 18-20 June 2014 Botswana-UPenn Partnership Partnership between Government of Botswana, University

More information

Cytology Update M Laing QEUH

Cytology Update M Laing QEUH Cytology Update M Laing QEUH Age change to 25 to 65 Age 25 to 50 Three yearly smear invitation Age 50 to 65 Five yearly smear invitation Women on non routine screening will be invited up to age 70 OUTCOME

More information

Preventing Cervical Cancer 2018 WHAT THIS WILL MEAN FOR PRIMARY CARE

Preventing Cervical Cancer 2018 WHAT THIS WILL MEAN FOR PRIMARY CARE Preventing Cervical Cancer 2018 WHAT THIS WILL MEAN FOR PRIMARY CARE DR GARY FENTIMAN, CLINICAL LEADER COLPOSCOPY, N C S P TAKE-HOME LESSONS Vaccination is Primary Prevention for Cervical Cancer Women

More information

and treating joins with the top of canal). at risk for cervical carcinomas, cervix.

and treating joins with the top of canal). at risk for cervical carcinomas, cervix. CERVICAL CANCER Worldwide, cervical cancer is twelfth most common and the fifth most deadly cancer in women. It affects about 16 per 100,000 women per year and kills about 9 per 100,000 per year. Cervical

More information

ANNEX 07 - LATVIA MEDIA GUIDE on CERVICAL CANCER IN LATVIA

ANNEX 07 - LATVIA MEDIA GUIDE on CERVICAL CANCER IN LATVIA European Commission Directorate C Public Health and Risk Assessment Health & Consumer Protection Directorate general GRANT AGREEMENT n 2007121 EUROCHIP-III European Cancer Health Indicator Project-III

More information

Illinois Health Connect Quality Assurance Tools

Illinois Health Connect Quality Assurance Tools Illinois Health Connect Quality Assurance Tools Margaret Kirkegaard, MD, MPH Medical Director, Illinois Health Connect mkirkegaard@automated-health.com ICAAP Medical Home Collaborative Disclosure for CME

More information

Cervical Cancer Prevention

Cervical Cancer Prevention Cervical Cancer Prevention Better Tools, Greater Coverage, Towards Elimination Issues and Opportunities Enriquito Lu (Ricky), MD, MPH Director Joint UNFPA-UNICEF-WHO Meeting: Where the World is Going and

More information

Cervical Cancer Screening. David Quinlan December 2013

Cervical Cancer Screening. David Quinlan December 2013 Cervical Cancer Screening David Quinlan December 2013 Cervix Cervical Cancer Screening Modest variation provincially WHO and UK begin at 25 stop at 60 Finland begin at 30 stop at 60 Rationale for

More information

National AIDS Spending Assessment Report Thai Working Group on National AIDS Spending Assessment Reporting date: July 12, 2012

National AIDS Spending Assessment Report Thai Working Group on National AIDS Spending Assessment Reporting date: July 12, 2012 National AIDS Spending Assessment Report 2010-2011 Thai Working Group on National AIDS Spending Assessment Reporting date: July 12, 2012 1 Table of Contents 1. Background... 6 2. Objectives... 6 3. Methodology...

More information

National Immunisation Conference 25th May 2018

National Immunisation Conference 25th May 2018 Cervical Cancer Prevention National Immunisation Conference 25th May 2018 Donal Brennan UCD Professor of Gynaecological Oncology Donal.Brennan@ucd.ie Outline Burden of cervical cancer Biology of HPV related

More information

Effectiveness of opportunistic screening for cancer of the cervix uteri

Effectiveness of opportunistic screening for cancer of the cervix uteri Original Article Effectiveness of opportunistic screening for cancer of the cervix uteri Roderick Busuttil, Miriam Dalmas, Albert Cilia Vincenti Abstract The incidence and mortality of uterine cervical

More information

How to successfully get a Flu Vaccination Policy accepted and implemented? the Thai experience

How to successfully get a Flu Vaccination Policy accepted and implemented? the Thai experience How to successfully get a Flu Vaccination Policy accepted and implemented? the Thai experience WHEII, June 5 th, 2012, Intercontinental Hotel, Bali, Indonesia Dr. Suwit Wibulpolprasert Senior Advisor on

More information

Breast and Cervical Cancers in Barbados A Situational Analysis HEATHER ARMSTRONG MEDICAL OFFICER OF HEALTH, MINISTRY OF HEALTH, BARBADOS

Breast and Cervical Cancers in Barbados A Situational Analysis HEATHER ARMSTRONG MEDICAL OFFICER OF HEALTH, MINISTRY OF HEALTH, BARBADOS Breast and Cervical Cancers in Barbados A Situational Analysis HEATHER ARMSTRONG MEDICAL OFFICER OF HEALTH, MINISTRY OF HEALTH, BARBADOS Contents Background Barbados Strategic Plan for the Prevention and

More information

Screening for cervical cancer in Hungary: New role for health visitors

Screening for cervical cancer in Hungary: New role for health visitors ORIGINAL ARTICLE Screening for cervical cancer in Hungary: New role for health visitors Döbrőssy Lajos, Kovács Attila, Budai András, Odor Andrea, Fehér Erika National Chief Medical Officer Office, Budapest,

More information

Government of Bangladesh

Government of Bangladesh Gavi Full Country Evaluations Findings Summary of recommendations Expanded Programme on Immunization Government of Gavi Secretariat With country-level partners, target efforts on low coverage areas and

More information

BRITISH COLUMBIA S CERVICAL CANCER SCREENING PROGRAM

BRITISH COLUMBIA S CERVICAL CANCER SCREENING PROGRAM BRITISH COLUMBIA S CERVICAL CANCER SCREENING PROGRAM DATE: NOVEMBER 19, 2016 PRESENTER: DR. DIRK VAN NIEKERK 1 Conflict of Interest Disclosure Nothing to disclose 2 ..in the beginning of the malady it

More information

IARC CERVIX CANCER SCREENING MEETING, APRIL The majority of cervical cancer cases today occur in the developing world.

IARC CERVIX CANCER SCREENING MEETING, APRIL The majority of cervical cancer cases today occur in the developing world. 7. Summary of data 7.1. Cervix cancer and screening 7.1.1. Incidence and mortality worldwide The majority of cervical cancer cases today occur in the developing world. However, before the introduction

More information

Genotype Testing on Current Cervical Cancer Algorithms

Genotype Testing on Current Cervical Cancer Algorithms Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

CITY OF VALLEJO HIDDENBROOKE IMPROVEMENT DISTRICT NO IMPROVEMENT LEVY ADMINISTRATION REPORT FISCAL YEAR

CITY OF VALLEJO HIDDENBROOKE IMPROVEMENT DISTRICT NO IMPROVEMENT LEVY ADMINISTRATION REPORT FISCAL YEAR CITY OF VALLEJO HIDDENBROOKE IMPROVEMENT DISTRICT NO. 1998-1 IMPROVEMENT LEVY ADMINISTRATION REPORT FISCAL YEAR 2010-11 December 17, 2010 Hiddenbrooke Improvement District No. 1998-1 Improvement Levy Administration

More information

SAULT STE. MARIE SAFE COMMUNITIES PARTNERSHIP COMMUNITY SCORECARD SEPTEMBER 2010*

SAULT STE. MARIE SAFE COMMUNITIES PARTNERSHIP COMMUNITY SCORECARD SEPTEMBER 2010* Attributes of Canadian Safe Communities Community Score 2010 Sault Ste. Marie Safe Communities Partnership (Total score 20/20) National Average (Total score 16.2/20) Average for Organizations within the

More information

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases

More information

A1. Does your government have a formal, written diabetes policy or strategy?

A1. Does your government have a formal, written diabetes policy or strategy? Survey of Diabetes Programs and Services in Canada Canadian Diabetes Association Diabetes Progress Report A1. Does your government have a formal, written diabetes policy or strategy? Yes. In October 2002,

More information

Linking Public Interests to Ensure Sustainable Statewide Quitlines

Linking Public Interests to Ensure Sustainable Statewide Quitlines Linking Public Interests to Ensure Sustainable Statewide Quitlines Public health tobacco prevention and control programs (TCPs) find themselves working within evershifting financial and political landscapes,

More information

Health economics for device developers: a framework for assessing commercial viability

Health economics for device developers: a framework for assessing commercial viability Health economics for device developers: a framework for assessing commercial viability Amanda Chapman & Samantha Burn University of Birmingham, UK. WHO Global forum on medical devices 23 rd November 2013

More information

DELTA DENTAL PREMIER

DELTA DENTAL PREMIER DELTA DENTAL PREMIER PARTICIPATING DENTIST AGREEMENT THIS AGREEMENT made and entered into this day of, 20 by and between Colorado Dental Service, Inc. d/b/a Delta Dental of Colorado, as first party, hereinafter

More information

07 August Dear Colleague,

07 August Dear Colleague, 07 August 2018 Dear Colleague, Further to our letter dated 9 May 2018, we are writing today to all healthcare professionals registered with CervicalCheck with updated advice and information regarding CervicalCheck.

More information

Empirical Evidence of P4P

Empirical Evidence of P4P Effect of Physician Pay-for-Performance (P4P) Incentives in a Large Primary Care Group Practice Presenter: Laurel Trujillo, MD 1 Collaborators: Harold Luft, PhD 2,3 Sukyung Chung, PhD 2,3 Latha Palaniappan,

More information

How to affect Financial Flows for Population Activities on Primary Level in Turkey

How to affect Financial Flows for Population Activities on Primary Level in Turkey Balancing the Primary Care and Secondary Care provision for more integration and better health outcomes! Galatasaray University, Istanbul; 9 September 2013 How to affect Financial Flows for Population

More information

The Renewed National Cervical Screening Program

The Renewed National Cervical Screening Program The Renewed National Cervical Screening Program Implementing the Changes IAN HAMMOND, ALISON LANG & TRACEY BESSELL What are the changes 5 yearly HPV test, partial genotyping Reflex liquid based cytology

More information

BC Cancer Cervix Screening 2015 Program Results. February 2018

BC Cancer Cervix Screening 2015 Program Results. February 2018 BC Cancer Cervix Screening 2015 Program Results BC Cancer Cervix Screening 2015 Program Results 2 Table of Contents BC Cancer Cervix Screening 2015 Program Results... 1 Table of Contents... 2 Program Overview...

More information

Developing your region

Developing your region Developing your region Welcome to this Contact a Family Webinar If there is a technical hitch, please do bear with us Those of you joining by pc, laptop, tablet or smart phone should now be able to see

More information

The Health Economics and Epidemiology Research Office (HE 2 RO): An overview of research methods and results

The Health Economics and Epidemiology Research Office (HE 2 RO): An overview of research methods and results The Health Economics and Epidemiology Research Office ( ): An overview of research methods and results Gesine Meyer-Rath Lawrence Long Kathryn Schnippel Introducing Collaboration between Wits and BU Established

More information

Cancer Integrated Prevention and Control in Shanghai. Wei Lu MD, MPH,PhD Shanghai Institutes of Preventive Medicine

Cancer Integrated Prevention and Control in Shanghai. Wei Lu MD, MPH,PhD Shanghai Institutes of Preventive Medicine Cancer Integrated Prevention and Control in Shanghai Wei Lu MD, MPH,PhD Shanghai Institutes of Preventive Medicine weiloo@scdc.sh.cn Shanghai Overview Demography ( 2003 ) Total residents 13,417,700 Sex

More information

Screening for Chronic Disease. Prof. A. Miller

Screening for Chronic Disease. Prof. A. Miller Screening for Chronic Disease Prof. A. Miller Non-communicable diseases (NCD) Comprise: Cardiovascular diseases Cerebrovascular diseases Cancer Chronic respiratory diseases Diabetes Non-communicable diseases

More information

The new Cervical Screening Test for Australian women: Louise Farrell

The new Cervical Screening Test for Australian women: Louise Farrell The new Cervical Screening Test for Australian women: Louise Farrell Outline and explain the changes to the National Cervical Screening Program due to commence in Dec 2017 LEARNING OBJECTIVES FOR TODAY

More information

Planning an effective HPV vaccination launch: The key indicators for success Joakim Dillner

Planning an effective HPV vaccination launch: The key indicators for success Joakim Dillner Planning an effective HPV vaccination launch: The key indicators for success Joakim Dillner Professor of Infectious Disease Epidemiology PI, International HPV Reference Center Director, Swedish Cervical

More information

Cervical screening update What you need to know about HPV primary testing

Cervical screening update What you need to know about HPV primary testing even if you ve had the HPV vaccine whether you re sexually active or not and whatever your sexual orientation And speak to your GP if you haven t GPN Insight January 2019 Cervical screening update What

More information

CERVICAL CANCERCONTROL PROGRAMME IN MALAWI OVERVIEW FOR 2015 PROGRAMME PERFORMANCE

CERVICAL CANCERCONTROL PROGRAMME IN MALAWI OVERVIEW FOR 2015 PROGRAMME PERFORMANCE CERVICAL CANCERCONTROL PROGRAMME IN MALAWI OVERVIEW FOR 2015 PROGRAMME PERFORMANCE Burden of Cervical Cancer & its risk Commonest in women accounting for 45% of all cancers factors in Malawi Over 2,300

More information

Cervical Skills Training Course

Cervical Skills Training Course Cervical Skills Training Course Competency Workbook Please return to: Christine Paterson Practice Nurse Advisor s Team Room 32 Modular Building Gartnavel Royal Hospital G12 0XH 0141 211 0615 Please return

More information

ก ก ก ก ก!. ก....!.. " #$ % P.1.

ก ก ก ก ก!. ก....!..  #$ % P.1. ก ก ก ก ก. ก...... P.1 ก ก ก ก 1 ก performance ก ก ก ก : ก ก ก 2 ก ก ก : ก / ก ก ( - ) ก ก ก ก 3 ก ก ก ก ก ก ก : ก ก 4 ก ก ก ก ก ก : ก P.2 ก ก :Cancer in Thailand Vol.IV, Cancer registry 2005-2007 ก ก

More information

IOM Committee on Review of Priorities in the National Vaccine Plan

IOM Committee on Review of Priorities in the National Vaccine Plan Challenges to Access: The Medical Home The medical home: Assumptions Access to a medical home = access to primary care = access to immunization services Desire for immunizations drives access to medical

More information

Molecular Triage: Partial and Extended Genotyping and More!

Molecular Triage: Partial and Extended Genotyping and More! Molecular Triage: Partial and Extended Genotyping and More! Thomas C. Wright, Jr. MD Professor Emeritus Columbia University, New York Pathologist, Enzo Clinical Laboratories, Farmingdale, NY Disclosures

More information

Human papillomavirus and vaccination for cervical cancer

Human papillomavirus and vaccination for cervical cancer Human papillomavirus and vaccination for cervical cancer Dorothy Machalek Department of Microbiology and Infectious Diseases Royal Women s Hospital, Melbourne, Australia VIRUSES AND CANCER Responsible

More information

Stepped Approach to Preventive Services Outreach in Primary Care Shana Ratner, MD Lindsey Franks, MSW Brooke McGuirt, MBA

Stepped Approach to Preventive Services Outreach in Primary Care Shana Ratner, MD Lindsey Franks, MSW Brooke McGuirt, MBA IHQI Seed Grant Program Symposium May 5, 2015 Stepped Approach to Preventive Services Outreach in Primary Care Shana Ratner, MD Lindsey Franks, MSW Brooke McGuirt, MBA The Problem A 58 year old healthy

More information

A workshop on screening for cervical

A workshop on screening for cervical Reports from the Field Workshop of the Uterine on Screening for Cancer Cervix in Central America1 A workshop on screening for cervical cancer was held in Managua, Nicaragua, from 21 to 23 November 1995.

More information

idc 20 AUTOMATED LIQUID-BASED CYTOLOGY SLIDE PREPARATION SYSTEM

idc 20 AUTOMATED LIQUID-BASED CYTOLOGY SLIDE PREPARATION SYSTEM idc 20 AUTOMATED LIQUID-BASED CYTOLOGY SLIDE PREPARATION SYSTEM ilsa : 16 rue de la Comtesse - 25640 MARCHAUX - FRANCE Phone : +33 (0) 381 579 034 Web : www.ilsa-france.com Email : contact@ilsa-france.com

More information

INFORMATION FOR RESEARCHERS REQUESTING DATA FROM THE NHVPR

INFORMATION FOR RESEARCHERS REQUESTING DATA FROM THE NHVPR INFORMATION FOR RESEARCHERS REQUESTING DATA FROM THE NHVPR What is the NHVPR? The National Human Papillomavirus Vaccination Program Register (NHVPR) is the Australian register which records HPV vaccine

More information

Primary HPV Screening It s screening Jim, but not as we know it. Adam Rosenthal PhD FRCOG Consultant Gynaecologist, Lead Colposcopist and HBPC

Primary HPV Screening It s screening Jim, but not as we know it. Adam Rosenthal PhD FRCOG Consultant Gynaecologist, Lead Colposcopist and HBPC Primary HPV Screening It s screening Jim, but not as we know it Adam Rosenthal PhD FRCOG Consultant Gynaecologist, Lead Colposcopist and HBPC Dominique Jean Larrey 1766-1842 (76 yr) Napoleon s chief battle

More information

Exemplar for Internal Achievement Standard. Biology Level 2

Exemplar for Internal Achievement Standard. Biology Level 2 Exemplar for internal assessment resource Biology for Achievement Standard 954 Exemplar for Internal Achievement Standard Biology Level 2 This exemplar supports assessment against: Achievement Standard

More information

Critical interactions between Global Fund-supported programmes and health systems: a case study in Thailand

Critical interactions between Global Fund-supported programmes and health systems: a case study in Thailand Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine ß The Author 2010; all rights reserved. Health Policy and Planning 2010;25:i53 i57 doi:10.1093/heapol/czq059

More information

Reporting to State Immunization Information Systems:

Reporting to State Immunization Information Systems: Reporting to State Immunization Information Systems: Community Pharmacy Perspective Sara E. Roszak, MPH, MA Director of Research National Association of Chain Drug Stores (NACDS) About NACDS Mission: Central

More information

Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer

Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer BJOG: an International Journal of Obstetrics and Gynaecology August 2004, Vol. 111, pp. 842 848 DOI: 1 0. 1111/j.1471-0528.2004.00210.x Comparison of HPV test versus conventional and automation-assisted

More information

Gavi, the Vaccine Alliance - Health System and Immunisation Strengthening (HSIS) Support Framework

Gavi, the Vaccine Alliance - Health System and Immunisation Strengthening (HSIS) Support Framework Gavi, the Vaccine Alliance - Health System and Immunisation Strengthening (HSIS) Support Framework I. Purpose This Framework sets out the principles and several essential requirements for Gavi s Health

More information

Infection as a non-communicable disease: A cervical cancer prevention primer

Infection as a non-communicable disease: A cervical cancer prevention primer Infection as a non-communicable disease: A cervical cancer prevention primer Brighter Future Today: Advocacy for HPV and Cervical Cancer Prevention Across the Life Course USAID Global Health Mini-University

More information

Recommandations SSGO dépistage cancer du col utérin. Pr Patrick Petignat University Hospitals of Geneva

Recommandations SSGO dépistage cancer du col utérin. Pr Patrick Petignat University Hospitals of Geneva Recommandations SSGO dépistage cancer du col utérin Pr Patrick Petignat University Hospitals of Geneva GRSSGO 2018 Pap test for cervical cancer screening: A success story Introduce essentially by gynecologists

More information

Cancer Screening Program in GEORGIA

Cancer Screening Program in GEORGIA Cancer Screening Program in GEORGIA International Health Policy Forum May 4-6 2017 Tbilisi, Georgia Prof. Rema Gvamichava Director Georgian National Screening Center Epidemiology Breast, Cervical and Colorectal

More information

Emerging Issues in Cancer Prevention and Control

Emerging Issues in Cancer Prevention and Control Emerging Issues in Cancer Prevention and Control Marcus Plescia, MD, MPH Director, Division of Cancer Prevention and Control Centers for Disease Control & Prevention National Center for Chronic Disease

More information

Partha Basu M.D. Screening Group/ Early Detection & Prevention Section

Partha Basu M.D. Screening Group/ Early Detection & Prevention Section VIA from Research to Programs - Opportunities and Challenges Partha Basu M.D. Screening Group/ Early Detection & Prevention Section Disclosures No financial disclosure NO conflict of interest to disclose

More information

An Audit of Pleural Fluid Sampling and Diagnostics at James Cook Hospital, Middlesbrough

An Audit of Pleural Fluid Sampling and Diagnostics at James Cook Hospital, Middlesbrough An Audit of Pleural Fluid Sampling and Diagnostics at James Cook Hospital, Middlesbrough Sue Saiger, BMS2 Dr. Graeme Watson, ST1 Histopathologist Dr. Ursula Earl, Consultant Histopathologist Background:

More information

Northern Ireland Cervical Screening Programme

Northern Ireland Cervical Screening Programme Northern Ireland Cervical Screening Programme ANNUAL REPORT & STATISTICAL BULLETIN 2010-2011 1 Report produced by : Quality Assurance Reference Centre, PHA Date of Publication: September 2012 2 Contents

More information

Human Papillomavirus Vaccination Programme in Malaysia

Human Papillomavirus Vaccination Programme in Malaysia 2016/SOM3/HWG-LSIF/WKSP/010 Session Human Papillomavirus Vaccination Programme in Malaysia Submitted by: Malaysia Accelerating Action on Human Papillomavirus and Cervical Cancer Prevention and Control

More information

Cancer Prevention and Control, Provider-Oriented Screening Interventions: Provider Incentives Cervical Cancer (2008 Archived Review)

Cancer Prevention and Control, Provider-Oriented Screening Interventions: Provider Incentives Cervical Cancer (2008 Archived Review) Cancer Prevention and Control, Provider-Oriented Screening Interventions: Provider Incentives Cervical Cancer (2008 Archived Review) Table of Contents Review Summary... 2 Intervention Definition... 2 Summary

More information

Access to Medicaid for Breast & Cervical Cancer Treatment:

Access to Medicaid for Breast & Cervical Cancer Treatment: Access to Medicaid for Breast & Cervical Cancer Treatment: What s New for Women s Health Connection and Your Patients? Presented by: Nevada Cancer Coalition This webinar supported by Nevada State Health

More information

The new face of diabetes care in New Zealand

The new face of diabetes care in New Zealand UPFRONT The new face of diabetes care in New Zealand ON 1 JULY, 2012 the Get Checked programme, under which diabetes follow-up care in New Zealand is funded, will cease to exist. In its place will be the

More information

14. Cancer of the Cervix Uteri

14. Cancer of the Cervix Uteri KEY FACTS 14. Cancer of the Cervix Uteri ICD-9 180 On average 78 cases of invasive cervical cancer were registered per year. Half of cases occurred under 49 years of age. 2% of female cancers. Higher than

More information

ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way

ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING Central Valley Public Health: Women's Way ICD-9-CM (Top 35) ICD-10-CM ICD-10-CM Description COMMENTS V10.3: Personal history of malignant neoplasm of Z85.3

More information

1.0 BACKGROUND. guide the response from

1.0 BACKGROUND. guide the response from National AIDS Commission 1.0 BACKGROUND The Government of Malawi established the National AIDS Commission (NAC), as a public trust in July 2001 to provide overall leadership and coordination of the national

More information

Cervical Cancer Prevention in the 21 st Century Changing Paradigms

Cervical Cancer Prevention in the 21 st Century Changing Paradigms Cervical Cancer Prevention in the 21 st Century Changing Paradigms Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Faculty Disclosures: Teresa M.

More information

HC 963 SesSIon november Department of Health. Young people s sexual health: the National Chlamydia Screening Programme

HC 963 SesSIon november Department of Health. Young people s sexual health: the National Chlamydia Screening Programme Report by the Comptroller and Auditor General HC 963 SesSIon 2008 2009 12 november 2009 Department of Health Young people s sexual health: the National Chlamydia Screening Programme 4 Summary Young people

More information

RTCOG Statement of Policy

RTCOG Statement of Policy Thai Journal of Obstetrics and Gynecology April 2009, vol. 17, pp. 66-69 RTCOG Statement of Policy A Policy Statement from the Royal Thai College of Obstetricians and Gynaecologists as issued by the RTCOG

More information

NPQR 2018 Qualified Clinical Data Registry (QCDR) Measures 21_18247_LS.

NPQR 2018 Qualified Clinical Data Registry (QCDR) Measures 21_18247_LS. NPQR 2018 Qualified Clinical Data Registry (QCDR) Measures 21_18247_LS MEASURE ID: NPQR1 MEASURE TITLE: Notification to the Ordering Provider Requesting Myoglobin or CK-MB in the Diagnosis of Suspected

More information